Filing Details

Accession Number:
0001140361-10-019199
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-05 13:00:00
Reporting Period:
2010-05-03
Filing Date:
2010-05-05
Accepted Time:
2010-05-05 17:21:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184151 R Conan Deady One Idexx Drive
Westbrook ME 04092
Corp Vp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-03 5,204 $13.32 26,915 No 4 M Direct
Common Stock Disposition 2010-05-03 5,204 $67.04 21,711 No 4 S Direct
Common Stock Acquisiton 2010-05-03 6,686 $13.32 28,397 No 4 M Direct
Common Stock Disposition 2010-05-03 6,686 $67.04 21,711 No 4 S Direct
Common Stock Acquisiton 2010-05-03 3,110 $17.14 24,821 No 4 M Direct
Common Stock Disposition 2010-05-03 3,110 $67.04 21,711 No 4 S Direct
Common Stock Acquisiton 2010-05-04 2,000 $17.14 23,711 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2010-05-03 5,204 $0.00 5,204 $13.32
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-05-03 6,686 $0.00 6,686 $13.32
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-05-03 3,110 $0.00 3,110 $17.14
Common Stock Incentive Stock Option (right to buy) Disposition 2010-05-04 2,000 $0.00 2,000 $17.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-02-12 No 4 M Direct
0 2012-02-12 No 4 M Direct
23,054 2013-02-06 No 4 M Direct
3,836 2013-02-06 No 4 M Direct
Footnotes
  1. The sale price reported above reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $66.84 to $67.19. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  2. Grant of option to buy shares of common stock exercisable as to 694 shares on 2/12/2006 and 7,510 shares on 2/12/2007.
  3. Grant of option to buy shares of common stock exercisable as to 8,000 shares on 2/12/2003, 2/12/2004, 2/12/2005, 7,306 shares on 2/12/2006 and 490 shares on 2/12/2007.
  4. Grant of option to buy shares of common stock exercisable as to 6,400 shares on 2/6/2004, 2/6/2005, 2/6/2006, 2/6/2007 and 564 shares on 2/6/2008.
  5. Grant of option to buy shares of common stock exercisable on the fifth anniversary date (2/6/2008) of the grant.